To further verify BCL2A1 as a novel diagnostic biomarker for patients with sepsis, we selected three other sepsis datasets (GSE28750, GSE69528, and GSE100159) to compare the diagnostic accuracy of BCL2A1 and FCGR1A in the disease. The gene discussed is BCL2A1; the disease is Sepsis.